AnalystsOlivia Brayer SaundersOlivia Brayer Saunders's Stock Forecasts
AnalystsOlivia Brayer Saunders
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#5129 out of 5549 analysts
Average Return
-16.21%
Win Rate
38%6 out of 16
Risk vs Reward
Poor
Good
Olivia Brayer Saunders's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Irulya Therapeutics IncIRLA | +63.29% | $19.36 | $31.62 | 2026-06-23 - 2026-10-29 | Strong Buy |
Mannkind CorpMNKD | +12.90% | $3.10 | $3.50 | 2026-10-20 - 2026-10-29 | Strong Buy |
United Therapeutics CorpUTHR | +11.40% | $532.82 | $593.54 | 2026-03-12 - 2026-10-29 | Strong Buy |
Braveheart Bio IncBRVE | +4.54% | $20.27 | $21.19 | 2026-10-20 - 2026-10-29 | Strong Buy |
Omeros CorpOMER | +2.82% | $18.43 | $18.95 | 2026-10-14 - 2026-10-29 | Strong Buy |
Olivia Brayer Saunders Analyst Color
Get additional color on Olivia Brayer Saunders's coverage of popular stocks
Olivia Brayer Saunders's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $86.00 | +49.59% | Reiterates | 11 days ago |
Mannkind CorpMNKD | 2 | Strong Buy | $8.00 | +128.57% | Reiterates | 11 days ago |
Braveheart Bio IncBRVE | 2 | Strong Buy | $40.00 | +88.77% | Reiterates | 11 days ago |
Ensysce Biosciences IncENSC | 1 | Strong Buy | $2.00 | +356.62% | Initiates Coverage On | 11 days ago |
Omeros CorpOMER | 2 | Strong Buy | $22.00 | +16.09% | Reiterates | 17 days ago |
Milestone Pharmaceuticals IncMIST | 1 | Strong Buy | $3.00 | +279.75% | Initiates Coverage On | 2 months ago |
Irulya Therapeutics IncIRLA | 2 | Strong Buy | $70.00 | +121.38% | Reiterates | 2 months ago |
Tenax Therapeutics IncTENX | 3 | Strong Buy | $35.00 | +1,781.72% | Reiterates | 3 months ago |
Pelthos Therapeutics IncPTHS | 1 | Strong Buy | $50.00 | +202.30% | Initiates Coverage On | 7 months ago |
United Therapeutics CorpUTHR | 1 | Strong Buy | $625.00 | +5.30% | Maintains | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.